Tel Aviv, Israel

Roy Maimon

This inventor holds 1 USPTO granted patent. Top assignee: Tel Aviv University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roy Maimon. Retrieved from https://idiyas.com/inventor/roy-maimon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roy Maimon: Innovator in Motor Neuron Disease Treatment

Introduction

Roy Maimon is a distinguished inventor based in Tel Aviv, Israel. He has made significant contributions to the field of medical research, particularly in the treatment of motor neuron diseases. His innovative approach has garnered attention in the scientific community.

Latest Patents

Roy Maimon holds a patent for the invention titled "MIRI26-5P FOR TREATING MOTOR NEURON DISEASES." This patent represents a crucial advancement in therapeutic options for individuals affected by these debilitating conditions. He has 1 patent to his name, showcasing his commitment to innovation in healthcare.

Career Highlights

Maimon is affiliated with Tel Aviv University, where he conducts research and collaborates with other experts in the field. His work at the university has positioned him as a key figure in the development of new treatments for motor neuron diseases.

Collaborations

Throughout his career, Roy Maimon has worked alongside notable colleagues, including Eran Perlson and Oded Behar. These collaborations have further enhanced his research and contributed to the advancement of medical science.

Conclusion

Roy Maimon's contributions to the treatment of motor neuron diseases highlight his role as an innovative inventor in the medical field. His work continues to inspire advancements that may improve the lives of many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…